JENNIFER CARLSON: Open Payments
NPI 1275929390 · BEDFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,245 in 58 payments from 13 companies in 2025. Trend: 2023 $527 · 2024 $457 · 2025 $1,245
Food & beverage: $1,245
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 23 | $416 |
| Exeltis, USA Inc. | 6 | $242 |
| SHIELD THERAPEUTICS INC | 3 | $131 |
| Astellas Pharma US Inc | 5 | $94 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $84 |
| Sumitomo Pharma America, Inc. | 5 | $83 |
| MILLICENT US INC | 4 | $71 |
| Organon LLC | 2 | $35 |
| Evofem Biosciences, Inc. | 2 | $27 |
| Boston Scientific Corporation | 1 | $19 |
Products named: ZURZUVAE, TWIRLA, ACCRUFER, Veozah, FEMLYV, MYFEMBREE, SLYND, NEXPLANON.
Industry payments across TX — which companies pay providers there.
